Richard S. Lindahl - Feb 28, 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief Financial Officer
Signature
/s/ Jennifer Lynn Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Feb 28, 2023
Transactions value $
-$13,296
Form type
4
Date filed
3/2/2023, 01:42 PM
Previous filing
Feb 27, 2023
Next filing
Mar 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$13.3K -1.07K -5.97% $12.38 16.9K Feb 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.